IDEXX LABORATORIES INC /DE Repayments of Secured Debt
IDEXX LABORATORIES INC /DE (IDXX) reported Repayments of Secured Debt of $250.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSecuredDebt · last filed 2026-02-20
- IDEXX LABORATORIES INC /DE repayments of secured debt for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- IDEXX LABORATORIES INC /DE repayments of secured debt for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- IDEXX LABORATORIES INC /DE repayments of secured debt for the quarter ending 2014-06-30 was $1.14M, a 371.49% increase year-over-year.
- IDEXX LABORATORIES INC /DE repayments of secured debt for the quarter ending 2014-03-31 was $253.00K, a 6.30% increase year-over-year.
- IDEXX LABORATORIES INC /DE repayments of secured debt for fiscal 2025 was $250.00M.
- IDEXX LABORATORIES INC /DE repayments of secured debt for fiscal 2024 was $0.00.
- IDEXX LABORATORIES INC /DE repayments of secured debt for fiscal 2023 was $0.00.
- IDEXX LABORATORIES INC /DE repayments of secured debt for fiscal 2014 was $1.39M, a 25.93% increase from fiscal 2013.
| Period end | Repayments of Secured Debt 3 month | Repayments of Secured Debt 6 month | Repayments of Secured Debt 9 month | Repayments of Secured Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $250.00M 10-K · filed 2026-02-20 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-20 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-20 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $0.00 derived: sum of 2 quarters · filed 2017-02-17 | $1.14M derived: sum of 3 quarters · filed 2017-02-17 | $1.39M 10-K · filed 2017-02-17 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $1.14M derived: sum of 2 quarters · filed 2015-10-28 | $1.39M 10-Q · filed 2015-10-28 | $1.64M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $1.39M 10-Q · filed 2015-07-30 | $1.64M derived: sum of 3 quarters · filed 2016-02-17 | $2.02M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $253.00K 10-Q · filed 2015-04-28 | $502.00K derived: sum of 2 quarters · filed 2016-02-17 | $880.00K derived: sum of 3 quarters · filed 2016-02-17 | $1.12M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $627.00K derived: sum of 2 quarters · filed 2016-02-17 | $869.00K derived: sum of 3 quarters · filed 2016-02-17 | $1.11M 10-K · filed 2016-02-17 |
| 2013-09-30 | $378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $620.00K derived: sum of 2 quarters · filed 2014-10-24 | $858.00K 10-Q · filed 2014-10-24 | $1.09M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $480.00K 10-Q · filed 2014-07-25 | $715.00K derived: sum of 3 quarters · filed 2015-02-17 | $945.00K derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $238.00K 10-Q · filed 2014-04-25 | $473.00K derived: sum of 2 quarters · filed 2015-02-17 | $703.00K derived: sum of 3 quarters · filed 2015-02-17 | $931.00K derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $465.00K derived: sum of 2 quarters · filed 2015-02-17 | $693.00K derived: sum of 3 quarters · filed 2015-02-17 | $917.00K 10-K · filed 2015-02-17 |
| 2012-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | $458.00K derived: sum of 2 quarters · filed 2013-10-22 | $682.00K 10-Q · filed 2013-10-22 | $902.00K derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23 | $452.00K 10-Q · filed 2013-07-23 | $672.00K derived: sum of 3 quarters · filed 2014-02-18 | $890.00K derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $224.00K 10-Q · filed 2013-04-23 | $444.00K derived: sum of 2 quarters · filed 2014-02-18 | $662.00K derived: sum of 3 quarters · filed 2014-02-18 | $877.00K derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $438.00K derived: sum of 2 quarters · filed 2014-02-18 | $653.00K derived: sum of 3 quarters · filed 2014-02-18 | $863.00K 10-K · filed 2014-02-18 |
| 2011-09-30 | $218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19 | $433.00K derived: sum of 2 quarters · filed 2012-10-19 | $643.00K 10-Q · filed 2012-10-19 | $851.00K derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $215.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20 | $425.00K 10-Q · filed 2012-07-20 | $633.00K derived: sum of 3 quarters · filed 2013-02-19 | $838.00K derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $210.00K 10-Q · filed 2012-04-20 | $418.00K derived: sum of 2 quarters · filed 2013-02-19 | $623.00K derived: sum of 3 quarters · filed 2013-02-19 | $823.00K derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $413.00K derived: sum of 2 quarters · filed 2013-02-19 | $613.00K derived: sum of 3 quarters · filed 2013-02-19 | $813.00K 10-K · filed 2013-02-19 |
| 2010-09-30 | $205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21 | $405.00K derived: sum of 2 quarters · filed 2011-10-21 | $605.00K 10-Q · filed 2011-10-21 | $800.00K derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22 | $400.00K 10-Q · filed 2011-07-22 | $595.00K derived: sum of 3 quarters · filed 2012-02-17 | $890.00K derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $200.00K 10-Q · filed 2011-04-21 | $395.00K derived: sum of 2 quarters · filed 2012-02-17 | $690.00K derived: sum of 3 quarters · filed 2012-02-17 | |
| 2009-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $490.00K derived: sum of 2 quarters · filed 2012-02-17 | $926.00K 10-K · filed 2012-02-17 | |
| 2009-09-30 | $295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22 | $731.00K 10-Q · filed 2010-10-22 | ||
| 2009-06-30 | $436.00K 10-Q · filed 2010-07-23 | |||
| 2008-12-31 | $595.00K 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |